InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Avagliano Mark, Directeur Commercial. Director active across 1 companies, notably G1 Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. The latest transaction was disclosed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
012,000 shares0
Common Stock
SEC:0001562180-22-000303·
012,000 shares0
Common Stock
SEC:0001562180-22-000303:0·
2 of 2 declarations
About Avagliano Mark
Mark Avagliano is the Chief Business Officer at G1 Therapeutics, Inc. He is responsible for the company's business strategy and development. G1 Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments.
